InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,960.00
(
-1.29%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.32
(
1.55%
)
Bitcoin
59,429.98
(
-5.90%
)
Post# of 252333
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 97125

Friday, 06/11/2010 5:06:07 AM

Friday, June 11, 2010 5:06:07 AM

Post# of 252333
This part was not in NVS’ own PR on the FTY720 advisory panel:

The panel later voted 21 to 3 against a question that asked if other drugs should be tried first, which means it backed the use of Gilenia as a first-line treatment for multiple sclerosis.


http://online.wsj.com/article/BT-CO-20100610-714300.html?mod=WSJ_World_MIDDLEHeadlinesEurope

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up